Lathrop Investment Management Corp Abb Vie Inc. Transaction History

Lathrop Investment Management Corp

$511 Million
Q2 2024

A detailed history of Lathrop Investment Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Lathrop Investment Management Corp holds 3,773 shares of ABBV stock, worth $698,608. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,773

Previous 3,773 -0.0%

Holding current value

$698,608

Previous $687,000 5.82%

% of portfolio

0.13%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $60,013 - $69,114	-415 Reduced 9.91%	3,773 $601,000
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $57,398 - $68,836	415 Added 11.0%	4,188 $677,000
Q1 2021 Apr 19, 2021	SELL	$102.3 - $112.62 $11,662 - $12,838	-114 Reduced 2.93%	3,773 $408,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $27,286 - $36,839	339 Added 9.55%	3,887 $416,000
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $8,591 - $10,083	-100 Reduced 2.74%	3,548 $311,000

Q2 2020 Jul 30, 2020	SELL	$73.37 - $98.18 $17,241 - $23,072	-235 Reduced 6.05%	3,648 $358,000
Q1 2020 Apr 15, 2020	SELL	$64.5 - $97.79 $203,949 - $309,211	-3,162 Reduced 44.88%	3,883 $296,000
Q4 2019 Jan 24, 2020	SELL	$72.13 - $90.25 $216 - $270	-3 Reduced 0.04%	7,045 $624,000
Q1 2019 Apr 19, 2019	SELL	$77.14 - $90.79 $9,642 - $11,348	-125 Reduced 1.74%	7,048 $568,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $90,928 - $112,139	1,168 Added 19.45%	7,173 $661,000
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $6,223 - $6,918	-70 Reduced 1.15%	6,005 $568,000
Q1 2018 Apr 16, 2018	BUY	$92.01 - $123.21 $17,941 - $24,025	195 Added 3.32%	6,075 $575,000
Q3 2017 Oct 11, 2017	BUY	$69.85 - $89.22 $410,717 - $524,613	5,880	5,880 $522,000

Others Institutions Holding ABBV

# of Institutions

3,647

Shares Held

1.23B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $327B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lathrop Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lathrop Investment Management Corp with notifications on news.

Account

Lathrop Investment Management Corp Abb Vie Inc. Transaction History